We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-6 of 6

Universities abroad experiment with no-fee licensing to drive biotech partnerships

  • Shook Hardy & Bacon LLP
  • -
  • Australia, Canada, European Union, United Kingdom, USA
  • -
  • May 16 2013

Universities in Australia, Canada, Europe, and the United Kingdom have reportedly embraced a 2010 Glasgow University initiative under which companies

UK and India to fund genomics and bioinformatics tech research

  • Shook Hardy & Bacon LLP
  • -
  • India, United Kingdom
  • -
  • April 4 2013

According to the U.K.'s Biotechnology and Biological Sciences Research Council (BBSRC), up to £10 million has been jointly pledged by the council and

Immbio gets funding to develop pneumococcal vaccine

  • Shook Hardy & Bacon LLP
  • -
  • United Kingdom
  • -
  • March 21 2013

U.K.-based vaccine developer, Immunobiology Ltd. (ImmBio), has announced that the U.K. Government-backed Biomedical Catalyst has awarded the company

Stem-cell research institute to open at the University of Cambridge

  • Shook Hardy & Bacon LLP
  • -
  • United Kingdom
  • -
  • August 16 2012

The Wellcome Trust and U.K. Medical Research Council will reportedly invest £8 million (US$12.5 million) to create a new stem-cell research center at the University of Cambridge

Uk seeks to revive biotech industry with $286-million fund

  • Shook Hardy & Bacon LLP
  • -
  • United Kingdom
  • -
  • April 19 2012

The United Kingdom (U.K.) is reportedly set to launch a $286-million fund operated by the Medical Research Council and Technology Strategy Board aimed at bridging the gap between medical breakthroughs and new drugs and devices

Wellcome Trust creates £200-million fund for UK, EU biotech startups

  • Shook Hardy & Bacon LLP
  • -
  • European Union, United Kingdom
  • -
  • March 29 2012

The U.K.-based Wellcome Trust has announced the creation of a £200-million fund to make long-term investments in British and European biotechnology startups